Merck provides update on IMPROVE-IT Trial
12 March 2013 | By Merck
IMPROVE-IT is an 18,141 patient event-driven trial...
List view / Grid view
News
American College of Cardiology and Boehringer Ingelheim collaborate to advance physician education with focus on China in 2013
11 March 2013 | By Boehringer Ingelheim
International peer-to-peer sharing...
New data reinforce strong long-term clinical performance of Abbott’s Absorb™ Bioresorbable Vascular Scaffold
11 March 2013 | By Abbott
Abbott announced positive long-term results...
BASF Pharma Callanish production approved by Korean FDA
11 March 2013 | By BASF
BASF Pharma Callanish has received approval to sell concentrated omega-3 fatty acids as active pharmaceutical ingredients...
Catalent announces major China expansion with two new facilities for Softgel Technologies and Clinical Supply Solutions businesses
11 March 2013 | By Catalent Pharma Solutions
Catalent announced two joint ventures...
Pharmaco-invasive strategy including Metalyse® delivers comparable clinical outcomes to primary PCI for STEMI patients
11 March 2013 | By Boehringer Ingelheim
New data presented...
New trial results support treatment with Inspra within first 24 hours of symptoms in patients with acute STEMI without heart failure
10 March 2013 | By Pfizer
Results from the REMINDER trial...
Gilead’s Ranexa® reduces angina frequency in study of chronic angina patients with type 2 diabetes
10 March 2013 | By Gilead Sciences
Gilead Sciences announced data from the Phase 4 TERISA study...
Abbott’s minimally invasive MitraClip® system for mitral regurgitation demonstrates positive clinical and quality- of-life results for patients too high risk for surgery
10 March 2013 | By Abbott
Data from the EVEREST II study...
Results from HPS2-THRIVE study of TREDAPTIVE™ presented at American College of Cardiology Scientific Sessions
9 March 2013 | By Merck
Results from the HPS2-THRIVE study...
GSK announces regulatory submission for albiglutide in Europe
7 March 2013 | By GlaxoSmithKline
GlaxoSmithKline announced the submission of a Marketing Authorisation Application for albiglutide...
Novo Nordisk’s award-winning NovoPen® 5 with easy-to-use memory function approved in China
7 March 2013 | By Biosector 2
NovoPen® 5 has just been approved for launch in China...
B&W Tek announces 1064nm portable Raman system
7 March 2013 | By B&W Tek
B&W Tek, Inc. is proud to announce the i-Raman® EX portable Raman spectrometer...
Roger M. Perlmutter appointed as President of Merck Research Laboratories
7 March 2013 | By Merck
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Roger M. Perlmutter, M.D., Ph.D., as executive vice president and president of Merck Research Laboratories (MRL), effective April 15. Dr. Perlmutter will succeed Peter S. Kim, Ph.D., who has served in the role…
ViiV Healthcare presents data from Phase III study of dolutegravir vs raltegravir in treatment-experienced adults with HIV-1
6 March 2013 | By GlaxoSmithKline
24-week data from Phase III SAILING study...
